相关实验视频

Updated: Jan 15, 2026

Analyses of Mitochondrial Calcium Influx in Isolated Mitochondria and Cultured Cells

Analyses of Mitochondrial Calcium Influx in Isolated Mitochondria and Cultured Cells

Published on: April 27, 2018

对线粒体升高的适应在左心室和右心室是不同的

Shanmugasundaram Pakkiriswami¹, Jae Hwi Sung¹, Kshama R Shah¹

¹Department of Integrative Biology and Physiology (S.P., J.H.S., K.R.S., U.Ö., M.K.S., F.F., H.C.V., E.S.C., J.C.L.), University of Minnesota, Minneapolis, MN.

Circulation research

|October 7, 2025

概括

患有MICU1 (线粒体吸收1) 干扰的小鼠由于高线粒体 (mtCa2+) 的心脏功能受损. 左心室通过减少mtCa2+吸收而恢复,与右心室不同,表明心力衰竭的潜在治疗点.

科学领域:

心脏病学心脏病学
线粒体生物学线粒体生物学
分子心脏病学分子心脏病学

背景情况:

线粒体 (mtCa2+) 调节ATP的产生,这对心肌细胞功能至关重要.
线粒体单载体复合体,特别是MICU1 (线粒体吸收1),控制mtCa2+流入.
升高的mtCa2+与心力衰竭有关,但其对心脏功能的直接影响尚不清楚.

研究的目的:

用小鼠模型研究升高mtCa²⁺对成年人心脏功能的影响.
探索对mtCa2+失调的反应中心室差异背后的机制.

主要方法:

产生的心肌细胞特异性诱导性Micu1淘汰赛 (Micu1cKO) 小鼠.
在tamoxifen诱导后1-9周,通过心声学评估心脏功能.
从左心室 (LV) 和右心室 (RV) 分离的线粒体,心肌细胞和组织提取物进行分析.

主要成果:

急性MICU1缺陷增加了mtCa2+和减少了线粒体呼吸在VR和LV.
RV功能仍然受损,而LV功能恢复了正常的mtCa2+和射出分数.
与下调的EMRE (基本MCU调节器) 相对应的LV恢复,由PKA调节的EMRE降解介导,表明在RV中缺少补偿机制.

结论:

升高的mtCa²⁺最初会损害心脏功能,但可以诱导特定于LV的适应性反应以恢复功能.
该LV使用一种包括EMRE下调的补偿途径来管理mtCa2+过载.
由于RV无法激活这种通路,这对治疗心力衰竭中的RV功能障碍有重大影响.

关键词:

和是最重要的.心灵心灵的心灵心灵的心灵心灵的心灵线粒体中的线粒体.肌细胞,心脏细胞.氧化应激是一种氧化应激.

更多相关视频

Author Spotlight: Mitochondrial Remodeling in Skeletal Muscle

Author Spotlight: Mitochondrial Remodeling in Skeletal Muscle

Published on: December 1, 2023

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension

Published on: January 20, 2023

相关概念视频

Mitral Regurgitation I: Introduction

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...

Mitral Stenosis I: Introduction

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...